Proportion of the target population who received in United States of America

United States of America: Proportion of the target population who received was 95.0% in 2024. ▲ Rising

Latest (2024)
95.0%
Change on year
unchanged
Rank
2nd
of 37 groups
All-time high
95.0%
in 2019
All-time low
85.0%
in 2000
Years of data
25
2000–2024

Proportion of the target population who received in United States of America, 2000–2024

0204060801002000201220242000: 852001: 862002: 862003: 862004: 862005: 862006: 862007: 862008: 872009: 882010: 892011: 902012: 912013: 912014: 922015: 932016: 942017: 942018: 942019: 952020: 952021: 952022: 952023: 952024: 95

Source: United Nations Statistics Division, SDG Global Database.

Analysis

In 2024, proportion of the target population who received in United States of America stood at 95.0%. That is the highest value across all 25 years on record.

Compared with earlier readings it is up 3.3% over ten years.

Over the whole period, proportion of the target population who received in United States of America peaked at 95.0% in 2019 and was at its lowest, 85.0%, in 2000.

United States of America ranks 2nd of 37 groups on this measure, in the top 10%.

The long-run direction has been consistently rising across the 25 years of available data.

Proportion of the target population who received in United States of America, year by year

Annual values for Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%) in United States of America, 2000 to 2024.
Year Value Change
2000 85.0%
2001 86.0% +1.2%
2002 86.0% +0.0%
2003 86.0% +0.0%
2004 86.0% +0.0%
2005 86.0% +0.0%
2006 86.0% +0.0%
2007 86.0% +0.0%
2008 87.0% +1.2%
2009 88.0% +1.1%
2010 89.0% +1.1%
2011 90.0% +1.1%
2012 91.0% +1.1%
2013 91.0% +0.0%
2014 92.0% +1.1%
2015 93.0% +1.1%
2016 94.0% +1.1%
2017 94.0% +0.0%
2018 94.0% +0.0%
2019 95.0% +1.1%
2020 95.0% +0.0%
2021 95.0% +0.0%
2022 95.0% +0.0%
2023 95.0% +0.0%
2024 95.0% +0.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 86.2% 85.0% 88.0% 10
2010s 92.3% 89.0% 95.0% 10
2020s 95.0% 95.0% 95.0% 5

Countries ranked near United States of America

  1. 1 Bahrain 99.0% compare
  2. 1 Brunei Darussalam 99.0% compare
  3. 1 Cuba 99.0% compare
  4. 1 Democratic People's Republic of Korea 99.0% compare
  5. 1 Hungary 99.0% compare
  6. 1 Iran (Islamic Republic of) 99.0% compare
  7. 1 Maldives 99.0% compare
  8. 1 Naoero 99.0% compare
  9. 1 Niue 99.0% compare
  10. 1 Oman 99.0% compare
  11. 1 Qatar 99.0% compare
  12. 1 Saint Vincent and the Grenadines 99.0% compare
  13. 1 Tonga 99.0% compare
  14. 1 Turkmenistan 99.0% compare
  15. 1 Uzbekistan 99.0% compare
  16. 1 Brunei Darussalam 99.0% compare

See the full ranking of 230 places →

More infrastructure data for United States of America

All data for United States of America →

Frequently asked questions

What is proportion of the target population who received in United States of America?
Proportion of the target population who received in United States of America was 95.0% in 2024, according to United Nations Statistics Division, SDG Global Database.
What is the highest proportion of the target population who received recorded in United States of America?
The highest recorded value was 95.0% in 2019.
What is the lowest proportion of the target population who received recorded in United States of America?
The lowest recorded value was 85.0% in 2000.
How does United States of America rank for proportion of the target population who received?
United States of America ranks 2nd out of 37 groups with data for 2024.
Is proportion of the target population who received rising or falling in United States of America?
Over the last ten years it is up 3.3%. The long-run trend across the full record is rising.
Where does this United States of America data come from?
The figures come from United Nations Statistics Division, SDG Global Database, published as part of Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under UN SDG Global Database (open, attribution requested).

Share, cite or embed this page

Cite this page

Proportion of the target population who received in United States of America. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 12 September 2026, from https://infrastructure.statizoid.com/stat/proportion-of-the-target-population-who-received-measles-containing-vaccine-second-dose/united-states-of-america/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://infrastructure.statizoid.com/stat/proportion-of-the-target-population-who-received-measles-containing-vaccine-second-dose/united-states-of-america/">Proportion of the target population who received in United States of America</a> — Statizoid

About this data

Indicator
Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%)
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
230 places, 4,598 data points, 2000–2024
Last refreshed